{"id":"faa1d8cf-5d6d-542b-b983-e2f6bf8ca6a3","stable_key":"7de430a5-1a36-5231-b931-35cc01d8f3bf:apap-apparent-selectivity-from-flux","predicate":"modulates","statement":"Paracetamol and salicylate are weak inhibitors of both isolated cyclooxygenase-1 and -2 but potent inhibitors of prostaglandin synthesis in intact cells if low concentrations of arachidonic acid are available, the effects of both being overcome by increased hydroperoxide levels; at low arachidonic acid concentrations cyclooxygenase-2 is the major isoenzyme involved when both are present, so these drugs may selectively inhibit synthesis involving cyclooxygenase-2 because the lower flux through that pathway produces less prostaglandin G2 than the pathway involving cyclooxygenase-1, and the authors propose the class name peroxide sensitive analgesic and antipyretic drugs.","claim_class":"hypothesis_link","status":"source_derived_draft","evidence_grade":"ungraded","direction":"context_dependent","is_public":true,"mechanism_event_id":"7c03560f-d2bc-5564-91fc-16573708c001","mechanism_event_label":"The apparent preference for the second enzyme may be nothing to do with binding it, and everything to do with how much peroxide each pathway makes.","subject":{"id":"b53aa1d7-8440-584c-aa8b-8a199aa832f1","slug":"peroxide-tone","display_name":"Ambient cellular hydroperoxide concentration","entity_type_key":"cellular_process"},"object":{"id":"52a2d1bd-f96d-5a87-84de-682aa1db8672","slug":"cox-selectivity-ratio","display_name":"The ratio of cyclooxygenase-1 to cyclooxygenase-2 inhibitory potency","entity_type_key":"cellular_process"},"evidence_count":1,"mechanism_event":{"id":"7c03560f-d2bc-5564-91fc-16573708c001","stable_key":"7de430a5-1a36-5231-b931-35cc01d8f3bf:apap-apparent-selectivity-from-flux-event","event_type":"biochemical_relationship","label":"The apparent preference for the second enzyme may be nothing to do with binding it, and everything to do with how much peroxide each pathway makes.","description":"Paracetamol and salicylate are weak inhibitors of both isolated cyclooxygenase-1 and -2 but potent inhibitors of prostaglandin synthesis in intact cells if low concentrations of arachidonic acid are available, the effects of both being overcome by increased hydroperoxide levels; at low arachidonic acid concentrations cyclooxygenase-2 is the major isoenzyme involved when both are present, so these drugs may selectively inhibit synthesis involving cyclooxygenase-2 because the lower flux through that pathway produces less prostaglandin G2 than the pathway involving cyclooxygenase-1, and the authors propose the class name peroxide sensitive analgesic and antipyretic drugs.","status":"provisional","compartment":null,"participants":[{"entity":{"id":"c8a31ed4-f2ca-5d43-8352-e9935129a785","slug":"ptgs2","display_name":"Cyclooxygenase-2 (PTGS2)","entity_type_key":"protein"},"role":"apparently_preferred_isoform","stoichiometry":null,"state_label":"","sequence_order":0,"notes":""},{"entity":{"id":"38f6dba9-8d52-5ea8-b718-20e264eed187","slug":"prostaglandin-g2","display_name":"Prostaglandin G2, the hydroperoxide product of the cyclooxygenase reaction","entity_type_key":"small_molecule"},"role":"flux_dependent_product","stoichiometry":null,"state_label":"","sequence_order":1,"notes":""},{"entity":{"id":"5739797a-3699-591b-95fd-f8b80e612713","slug":"salicylate","display_name":"Salicylate / salicylic acid","entity_type_key":"small_molecule"},"role":"co_classified_drug","stoichiometry":null,"state_label":"","sequence_order":2,"notes":""},{"entity":{"id":"09eb9a27-60b2-5cd7-8b29-102b63332ee8","slug":"psaad-class","display_name":"Peroxide-sensitive analgesic and antipyretic drugs as a proposed drug class","entity_type_key":"chemical_species"},"role":"proposed_class","stoichiometry":null,"state_label":"","sequence_order":3,"notes":""},{"entity":{"id":"b53aa1d7-8440-584c-aa8b-8a199aa832f1","slug":"peroxide-tone","display_name":"Ambient cellular hydroperoxide concentration","entity_type_key":"cellular_process"},"role":"subject","stoichiometry":null,"state_label":"","sequence_order":4,"notes":""},{"entity":{"id":"52a2d1bd-f96d-5a87-84de-682aa1db8672","slug":"cox-selectivity-ratio","display_name":"The ratio of cyclooxygenase-1 to cyclooxygenase-2 inhibitory potency","entity_type_key":"cellular_process"},"role":"target","stoichiometry":null,"state_label":"","sequence_order":5,"notes":""}]},"contexts":[{"dimension":"evidence_span","value_text":"{\"source_cache\": \"artifacts/paracetamol-research/15035793.abstract.txt\", \"locator\": \"Indexed abstract; zero-based, end-exclusive Unicode character offsets\", \"file_sha256\": \"f72415969de66bea6c0588049cbe1fd1a4b23195c0e2f5a60293eaf99a0f641e\", \"start_char\": 0, \"end_char\": 1279, \"text_sha256\": \"f72415969de66bea6c0588049cbe1fd1a4b23195c0e2f5a60293eaf99a0f641e\"}","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"experimental_model","value_text":"Review of the mechanism of paracetamol and salicylate as peroxide-sensitive inhibitors","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"exposure","value_text":"Paracetamol and salicylate at low arachidonic acid concentrations","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"limitations","value_text":"A review proposing a drug class rather than a new measurement. Its argument that apparent cyclooxygenase-2 selectivity arises from flux rather than binding is the useful part.","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"nutrient_topic","value_text":"Paracetamol research collection; topical membership is not evidence of a direct clinical effect, and the drug is recorded separately from the metabolites NAPQI and AM404.","comparator":null,"unit":null,"notes":"","entity":{"slug":"acetaminophen","display_name":"Paracetamol","entity_type_key":"drug"}},{"dimension":"organism","value_text":"Human and enzyme","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"plain_language","value_text":"The apparent preference for the second enzyme may be nothing to do with binding it, and everything to do with how much peroxide each pathway makes.","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"primary_references","value_text":"[apap-p15035793] Mechanisms of action of paracetamol and related analgesics. (2003). https://pubmed.ncbi.nlm.nih.gov/15035793/ DOI: 10.1163/156856003322699573","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"tissue_or_cell_type","value_text":"Cyclooxygenase","comparator":null,"unit":null,"notes":"","entity":null}],"evidence":[{"id":"b3f5a5fb-837d-5904-8e15-f6f84af8c29b","evidence_kind":"source_excerpt","locator":"Lines 181-192","start_line":181,"end_line":192,"excerpt":"### apap-apparent-selectivity-from-flux\nParacetamol and salicylate are weak inhibitors of both isolated cyclooxygenase-1 and -2 but potent inhibitors of prostaglandin synthesis in intact cells if low concentrations of arachidonic acid are available, the effects of both being overcome by increased hydroperoxide levels; at low arachidonic acid concentrations cyclooxygenase-2 is the major isoenzyme involved when both are present, so these drugs may selectively inhibit synthesis involving cyclooxygenase-2 because the lower flux through that pathway produces less prostaglandin G2 than the pathway involving cyclooxygenase-1, and the authors propose the class name peroxide sensitive analgesic and antipyretic drugs.\nCondition category: normal\nnutrient_topic: Paracetamol research collection; topical membership is not evidence of a direct clinical effect, and the drug is recorded separately from the metabolites NAPQI and AM404.\nplain_language: The apparent preference for the second enzyme may be nothing to do with binding it, and everything to do with how much peroxide each pathway makes.\norganism: Human and enzyme\ntissue_or_cell_type: Cyclooxygenase\nexperimental_model: Review of the mechanism of paracetamol and salicylate as peroxide-sensitive inhibitors\nlimitations: A review proposing a drug class rather than a new measurement. Its argument that apparent cyclooxygenase-2 selectivity arises from flux rather than binding is the useful part.\nexposure: Paracetamol and salicylate at low arachidonic acid concentrations\nevidence_span: {\"source_cache\": \"artifacts/paracetamol-research/15035793.abstract.txt\", \"locator\": \"Indexed abstract; zero-based, end-exclusive Unicode character offsets\", \"file_sha256\": \"f72415969de66bea6c0588049cbe1fd1a4b23195c0e2f5a60293eaf99a0f641e\", \"start_char\": 0, \"end_char\": 1279, \"text_sha256\": \"f72415969de66bea6c0588049cbe1fd1a4b23195c0e2f5a60293eaf99a0f641e\"}\n[apap-p15035793] Mechanisms of action of paracetamol and related analgesics. (2003). https://pubmed.ncbi.nlm.nih.gov/15035793/ DOI: 10.1163/156856003322699573","model_system":"Review of the mechanism of paracetamol and salicylate as peroxide-sensitive inhibitors","directness":"author_interpretation","verification_status":"source_derived_draft","notes":"Exact curation-document quotation, not publisher quotation. Study references: [apap-p15035793] Mechanisms of action of paracetamol and related analgesics. (2003). https://pubmed.ncbi.nlm.nih.gov/15035793/ DOI: 10.1163/156856003322699573","relationship":"supports","weight":1.0,"link_notes":"","source":{"id":"9ee11177-f860-5877-bb82-f4ee4acdc538","stable_key":"import-7de430a5-1a36-5231-b931-35cc01d8f3bf","title":"Paracetamol: the enzyme it reduces rather than blocks, the isoform that turned out not to exist, the metabolite that carries the analgesia, and the metabolite that destroys the liver (2026-09-22)","document_type":"imported_text","citation_label":"AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text.","file_path":"","sha256":"9c145887aa10fa7b85f54712e0b41fd9e04fb9544d3182793dd84414dbf8c2ae","revision_id":"c3e7827a-4f10-55e0-97b9-5782b044f7cc","review_status":"unverified_draft","notes":""}}],"relations":[],"conflicts":[],"corrections":[],"research":null}